Beam Therapeutics Income Statement (2019-2026) | BEAM

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.01M0.76M51.07M8.43M16.65M15.80M20.04M24.21M20.12M17.19M316.19M7.41M11.77M14.27M30.07M7.47M8.47M9.70M114.11M31.74M
Operating items
Research & Development (Quarter)
45.58M54.62M96.78M65.41M74.56M85.29M86.34M99.65M97.61M100.05M140.08M84.82M87.04M94.26M101.44M98.82M101.76M109.77M99.28M104.52M
Selling, General & Administrative (Quarter)
13.40M15.77M17.77M19.25M24.06M21.82M22.68M23.49M24.66M25.41M43.26M26.72M29.63M26.52M28.66M27.94M26.86M26.74M32.28M34.43M
Other Operating Expenses (Quarter)
-365.46M-507.37M-105.58M-114.08M-123.64M-124.54M384.59M
Operating Expenses (Quarter)
58.98M70.40M114.55M84.66M98.62M107.10M-256.44M123.14M122.26M125.46M-324.04M5.96M2.59M120.77M6.46M126.76M128.62M11.97M516.14M138.95M
Operating Income (Quarter)
-58.97M-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M-17.45M-107.22M
EBIT (Quarter)
-58.97M-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M-17.45M-107.22M
Non-operating items
Non Operating Investment Income (Quarter)
25.81M-4.89M-4.27M-7.68M-4.12M10.43M21.58M-12.80M6.15M-11.22M-0.72M-3.35M-7.59M-2.06M-1.09M-2.08M4.42M4.94M-3.33M0.02M
Interest & Investment Income (Quarter)
-0.05M0.01M0.05M0.64M2.06M4.98M7.61M9.96M11.95M12.70M12.06M11.85M14.19M12.13M10.93M9.86M12.33M10.90M10.64M9.87M
Other Non Operating Income (Quarter)
-42.30M35.80M7.40M13.60M12.20M-4.90M3.00M5.60M-0.90M4.70M-1.90M-2.90M5.50M-0.20M-0.13M3.20M1.15M-2.76M9.52M2.50M
Non Operating Income (Quarter)
-17.28M41.52M-1.22M7.01M10.02M9.64M51.64M2.47M19.37M12.18M11.30M5.46M13.88M9.84M9.68M10.96M17.86M14.08M261.74M12.90M
Net income details
EBT (Quarter)
-61.34M-28.12M-64.71M-95.65M-176.20M-81.67M-37.35M-89.15M-82.78M-96.09M144.16M-92.71M-91.01M-96.67M-90.35M-109.54M-102.29M-112.73M244.30M-98.31M
Tax Provisions (Quarter)
2.41M1.00M1.40M0.04M-16.80M
Profit After Tax (Quarter)
-76.25M-28.12M-64.73M-69.21M-71.95M-110.06M-36.10M-96.46M-82.78M-96.10M145.83M-98.67M-91.05M-96.67M-91.43M-108.33M-0.20M-0.20M244.73M-96.50M
Income from Continuing Operations (Quarter)
-61.34M-28.12M-64.71M-95.65M-176.20M-84.08M-38.35M-89.15M-82.78M-96.09M142.76M-92.71M-91.05M-96.67M-90.35M-109.54M-102.29M-112.73M261.10M-98.31M
Consolidated Net Income (Quarter)
-61.34M-28.12M-64.71M-95.65M-176.20M-84.08M-38.35M-89.15M-82.78M-96.09M142.76M-92.71M-91.05M-96.67M-90.35M-109.54M-102.29M-112.73M261.10M-98.31M
Income towards Parent Company (Quarter)
-61.34M-28.12M-64.71M-95.65M-176.20M-84.08M-38.35M-89.15M-82.78M-96.09M142.76M-92.71M-91.05M-96.67M-90.35M-109.54M-102.29M-112.73M261.10M-98.31M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-76.25M-28.12M-64.71M-69.21M-71.95M-109.58M-38.35M-96.46M-82.78M-96.09M142.80M-98.67M-91.05M-96.67M-90.35M-108.33M-102.29M-112.73M244.30M-94.32M
Additional items
EPS (Basic) (Quarter)
-1.23-0.42-1.01-1.01-1.02-1.56-0.55-1.33-1.08-1.221.85-1.21-1.11-1.17-1.10-1.23-1.00-1.102.47-0.91
EPS (Diluted) (Quarter)
-1.23-0.42-1.01-1.01-1.02-1.56-0.55-1.33-1.08-1.221.85-1.21-1.11-1.17-1.10-1.23-1.00-1.102.47-0.91
Shares Outstanding (Quarter)
62.21M66.38M64.23M68.70M70.21M70.34M70.02M72.27M76.34M79.02M77.15M81.70M82.31M82.41M82.31M87.98M102.00M102.57M98.91M103.26M
Shares Outstanding (Diluted) (Quarter)
62.21M66.38M64.23M68.70M70.21M70.34M70.02M72.27M76.34M79.02M77.15M81.70M82.31M82.41M82.31M87.98M102.00M102.57M98.91M103.26M
EBITDA (Quarter)
-58.97M-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M-17.45M-107.22M
Interest Expenses (Quarter)
2.31M3.06M4.41M20.07M96.29M4.60M0.08M0.18M1.24M0.49M22.46M0.43M0.16M0.00M24.95M0.12M0.05M0.01M0.96M
Tax Rate (Quarter)
-2.95-2.680.97-0.04-6.88